“…Recently, the addition of a methyl (–CH 3 ) group to small organic molecules has gained recognition in medicinal chemistry and the pharmaceutical industry due to its potential to modulate and enhance the drug-bioreceptor interaction, bioavailability, solubility, and metabolism, giving rise to the “magic methyl effect”. 1 Consequently, several indirect- and direct methylation protocols have been developed using a variety of methylation reagents, including iodomethane, 2 tert -butyl hydroperoxide, 3 tetramethyltin, 4 diazomethane, 5 dicumyl peroxide, 6 methylboronic acid, 7 potassium methyltrifluoroborate, 8 methylmagnesium chloride, 9 dimethyl sulfoxide (DMSO), 10 acetic acid, 11 and trimethylaluminium. 12 Compared to other methylation reagents, DMSO activation and the generation of the methyl-radical (˙CH 3 ) in situ for the rapid construction of methylated (hetero)arenes have attracted significant interest (Scheme 1) 13 because DMSO is non-toxic, widely available, and works with the action of the conventional Fenton reagent (H 2 O 2 and Fe 2+ /Fe 3+ , Scheme 1a).…”